PULMONARY FIBROSIS
Clinical trials for PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for lung scarring in Long-Term safety trial
Disease control Not yet recruitingThis study looks at the long-term safety of a drug called admilparant in people with pulmonary fibrosis (lung scarring). About 2,277 adults who finished earlier studies will take the drug and be monitored for side effects. The goal is to see if the drug is safe to use over time, …
Matched conditions: PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug duo aims to help lung fibrosis patients breathe easier
Disease control Not yet recruitingThis study tests whether adding nerandomilast to the standard drug mycophenolate is safe and tolerable for people with pulmonary fibrosis (lung scarring). About 120 adults with various types of lung fibrosis will take the combination for 4 months. The main goal is to see how many…
Matched conditions: PULMONARY FIBROSIS
Phase: PHASE4 • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New PET tracer aims to spot scarring in organs without a needle
Diagnosis Not yet recruitingThis study will test a new imaging agent called 68Ga-1A12, which is used in a PET scan to detect fibrosis (scarring) in organs like the lungs. The goal is to see if this scan can diagnose fibrosis earlier and more accurately than current methods, which often require invasive biop…
Matched conditions: PULMONARY FIBROSIS
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
How safe is bronchoscopy for ILD patients? new study aims to find out
Knowledge-focused Not yet recruitingThis study will track 427 adults with interstitial lung disease (ILD) who need a bronchoscopy as part of their care. Researchers want to see how often complications happen within 30 days after the procedure. The goal is to better understand the risks so doctors can make safer cho…
Matched conditions: PULMONARY FIBROSIS
Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC